AkzoNobel: shareholders approve all-share merger with Axalta
- AkzoNobel shareholders at the EGM approved the all-share merger with Axalta and all related resolutions.
- Axalta shareholders also approved the merger at their Special General Meeting.
- Completion is subject to required regulatory approvals and other customary closing conditions, with finalisation expected end‑2026 or early‑2027.
- Resolutions included amendments to the Articles, authorization to issue shares for the merger, proposed board appointments and a remuneration policy; Greg Poux‑Guillaume will be CEO and Ben Noteboom Vice‑Chair of the combined company.
EGM and shareholder approvals
Shareholders at AkzoNobel's Extraordinary General Meeting voted overwhelmingly in favour of all resolutions related to the proposed all-share merger with Axalta. Axalta shareholders likewise approved the merger at their Special General Meeting.
Resolutions passed
The EGM approved the Merger, amendments to the Articles of Association, authorization to issue shares in connection with the Merger, the proposed appointments to the Board of Directors and the proposed remuneration policy.
Next steps and timing
With the required approvals obtained at both meetings, the Merger can move to the next phase but remains subject to receipt of required regulatory approvals and other customary closing conditions. Once those conditions have been met, the Merger is expected to be finalised at the end of 2026 or the beginning of 2027.
Leadership
AkzoNobel CEO Greg Poux‑Guillaume will serve as CEO of the combined company and Ben Noteboom will serve as Vice‑Chair.
Further information
Further information and an overview of the voting results will be published on AkzoNobel's website.
Source: AkzoNobel